4
Changes in Ownership
Vistagen Therapeutics, Inc. Filed Acc 0001415889-13-001270
CHIEF EXECUTIVE OFFICER acquired 50,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Singh Shawn CHIEF EXECUTIVE OFFICER | 2013-06-27 | Option exercise | +50,000 | $0.64 | $32,000 | 302,174 | I |
| Derivatives | |||||||
| Singh Shawn CHIEF EXECUTIVE OFFICER | 2013-06-27 | Option exercise · Warrant | −50,000 | 1,450,000 | D | ||
Loading xslF345X03/form4-06272013_070617.xml…